Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001010195 | SCV001170352 | likely benign | Hereditary cancer-predisposing syndrome | 2019-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001461645 | SCV001665548 | likely benign | Familial adenomatous polyposis 2 | 2022-08-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001010195 | SCV004358554 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-17 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001461645 | SCV005429817 | likely benign | Familial adenomatous polyposis 2 | 2024-06-09 | criteria provided, single submitter | clinical testing |